Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-80
SponsorFederal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health
About this trial
The study is aimed at the investigation of the association of biomarkers of circadian rhythms with sleep characteristics and stroke outcome in acute stroke patients. It is designed as an observational cohort study with the retrospective and prospective longitudinal arms.
Eligibility criteria
Qualifiers
acute (symptom onset to admission <1 days) ischemic stroke
ischemic stroke affecting the branches of anterior cerebral artery, middle cerebral artery and posterior cerebral artery
age 18-80 years
moderate or severe stroke (National Institutes of Health Stroke Scale, NIHSS>=5)
Disqualifiers
secondary parenchymal hemorrhage (>hemorrhage index -2)
clinically unstable or life-threatening conditions
known progressive neurological diseases
known psychiatric diseases
Trial design
Treatments tested in this trial
- No intervention is planned
Treatment groups
250 Participants
are divided into 2 treatment groups Source ClinicalTrials.gov